miR-221-3p promotes hepatocellular carcinogenesis by downregulating O6-methylguanine-DNA methyltransferase

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. PMID:30207593. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Schottenfeld D, Fraumeni JF. 2006. Cancer epidemiology and prevention. Irvine (CA) (USA): Oxford University Press.
   Google Scholar
• Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg. 2009;249:118–123. PMID:19106686. doi:10.1097/SLA.0b013e3181904988.
   PubMed Web of Science ®Google Scholar
• Liu X, Liao W, Yuan Q, Ou Y, Huang J. TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells. Oncotarget. 2015;6:34309–34320. PMID:26418879. doi:10.18632/oncotarget.5295.
   PubMed Web of Science ®Google Scholar
• Karavias D, Maroulis I, Papadaki H, Gogos C, Kakkos S, Karavias D, Bravou V. Overexpression of CDT1 is a predictor of poor survival in patients with hepatocellular carcinoma. J Gastrointest Surg. 2016;20:568–579. PMID:26408331. doi:10.1007/s11605-015-2960-7.
   PubMed Web of Science ®Google Scholar
• Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene. 2010;29:4989–5005. PMID:20639898. doi:10.1038/onc.2010.236.
   PubMed Web of Science ®Google Scholar
• Ezaka K, Kanda M, Sugimoto H, Shimizu D, Oya H, Nomoto S, Sueoka S, Tanaka Y, Takami H, Hashimoto R, et al. Reduced expression of adherens junctions associated protein 1 predicts recurrence of hepatocellular carcinoma after curative hepatectomy. Ann Surg Oncol. 2015;22(Suppl 3):S1499–507. PMID:26122373. doi:10.1245/s10434-015-4695-9.
   PubMedGoogle Scholar
• Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z, Deng X, Chen H, Shen B, Peng C, et al. Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma. Oncogene. 2016;35:1575–1584. PMID:26073087. doi:10.1038/onc.2015.223.
   PubMed Web of Science ®Google Scholar
• Hu Z, Zhao W. Novel insights into the molecular mechanisms of alpha-fetoprotein expression and malignant phenotypes of hepatocellular carcinoma. Cell Mol Immunol. 2012;9:7–8. PMID:21860406. doi:10.1038/cmi.2011.30.
   PubMed Web of Science ®Google Scholar
• Merle P, Trepo C. Molecular mechanisms underlying hepatocellular carcinoma. Viruses. 2009;1:852–872. PMID:21994573. doi:10.3390/v1030852.
   PubMed Web of Science ®Google Scholar
• Cai K, Shen F, Cui JH, Yu Y, Pan HQ. Expression of miR-221 in colon cancer correlates with prognosis. Int J Clin Exp Med. 2015;8:2794–2798. PMID:25932237.
   PubMed Web of Science ®Google Scholar
• Sun L, Hu J, Xiong W, Chen X, Li H, Jie S. MicroRNA expression profiles of circulating microvesicles in hepatocellular carcinoma. Acta Gastroenterol Belg. 2013;76:386–392. PMID:24592541.
   PubMed Web of Science ®Google Scholar
• Giordano S, Columbano A. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology. 2013;57:840–847. PMID:23081718. doi:10.1002/hep.26095.
   PubMed Web of Science ®Google Scholar
• Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, Voros D. Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog. 2013;52:297–303. PMID:22213236. doi:10.1002/mc.21864.
   PubMed Web of Science ®Google Scholar
• Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol. 2011;223:102–115. PMID:21125669. doi:10.1002/path.2806.
   PubMed Web of Science ®Google Scholar
• Shen G, Rong X, Zhao J, Yang X, Li H, Jiang H, Zhou Q, Ji T, Huang S, Zhang J, et al. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma. Carcinogenesis. 2014;35:2748–2755. PMID:25280563. doi:10.1093/carcin/bgu208.
   PubMed Web of Science ®Google Scholar
• Rong M, Chen G, Dang Y. Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro. BMC Cancer. 2013;13:21. PMID:23320393. doi:10.1186/1471-2407-13-21.
   PubMed Web of Science ®Google Scholar
• Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, et al. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene. 2008;27:5651–5661. PMID:18521080. doi:10.1038/onc.2008.178.
   PubMed Web of Science ®Google Scholar
• Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A. miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A. 2010;107:264–269. PMID:20018759. doi:10.1073/pnas.0907904107.
   PubMed Web of Science ®Google Scholar
• Li CC, Yu Z, Cui LH, Piao JM, Liu M. Role of P14 and MGMT gene methylation in hepatocellular carcinomas: a meta-analysis. Asian Pac J Cancer Prev. 2014;15:6591–6596. PMID:25169493. doi:10.7314/apjcp.2014.15.16.6591.
   PubMedGoogle Scholar
• Felsberg J, Thon N, Eigenbrod S, Hentschel B, Sabel MC, Westphal M, Schackert G, Kreth FW, Pietsch T, Loffler M, et al. Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. Int J Cancer. 2011;129:659–670. PMID:21425258. doi:10.1002/ijc.26083.
   PubMed Web of Science ®Google Scholar
• Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 1999;59:793–797. PMID:10029064.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513–10518. PMID:18663219. doi:10.1073/pnas.0804549105.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408. PMID:11846609. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Li B, Xu WW, Han L, Chan KT, Tsao SW, Lee NPY, Law S, Xu LY, Li EM, Chan KW, et al. MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF. Oncogene. 2017;36:3986–4000. PMID:28288140. doi:10.1038/onc.2017.29.
   PubMed Web of Science ®Google Scholar
• Kanno S, Nosho K, Ishigami K, Yamamoto I, Koide H, Kurihara H, Mitsuhashi K, Shitani M, Motoya M, Sasaki S, et al. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer. Carcinogenesis. 2017;38:425–431. PMID:28186267. doi:10.1093/carcin/bgx013.
   PubMed Web of Science ®Google Scholar
• Madhavan D, Peng C, Wallwiener M, Zucknick M, Nees J, Schott S, Rudolph A, Riethdorf S, Trumpp A, Pantel K, et al. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis. Carcinogenesis. 2016;37:461–470. PMID:26785733. doi:10.1093/carcin/bgw008.
   PubMed Web of Science ®Google Scholar
• Chang JH, Hwang YH, Lee DJ, Kim DH, Park JM, Wu HG, Kim IA. MicroRNA-203 modulates the radiation sensitivity of human malignant glioma cells. Int J Radiat Oncol Biol Phys. 2016;94:412–420. PMID:26678661. doi:10.1016/j.ijrobp.2015.10.001.
   PubMed Web of Science ®Google Scholar
• Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Croce CM, Bolondi L, Negrini M. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res. 2009;15:5073–5081. PMID:19671867. doi:10.1158/1078-0432.CCR-09-0092.
   PubMed Web of Science ®Google Scholar
• Igoucheva O, Alexeev V. MicroRNA-dependent regulation of cKit in cutaneous melanoma. Biochem Biophys Res Commun. 2009;379:790–794. PMID:19126397. doi:10.1016/j.bbrc.2008.12.152.
   PubMed Web of Science ®Google Scholar
• de Conti A, Ortega JF, Tryndyak V, Dreval K, Moreno FS, Rusyn I, Beland FA, Pogribny IP. MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis. Oncotarget. 2017;8:88517–88528. PMID:29179453. doi:10.18632/oncotarget.19774.
   PubMedGoogle Scholar
• Lupini L, Bassi C, Ferracin M, Bartonicek N, D’Abundo L, Zagatti B, Callegari E, Musa G, Moshiri F, Gramantieri L, et al. miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs. Front Genet. 2013;4:64. PMID:23630541. doi:10.3389/fgene.2013.00064.
   PubMedGoogle Scholar
• Fu X, Wang Q, Chen J, Huang X, Chen X, Cao L, Tan H, Li W, Zhang L, Bi J, et al. Clinical significance of miR-221 and its inverse correlation with p27Kip(1) in hepatocellular carcinoma. Mol Biol Rep. 2011;38:3029–3035. PMID:20146005. doi:10.1007/s11033-010-9969-5.
   PubMed Web of Science ®Google Scholar
• Wei WF, Zhou CF, Wu XG, He LN, Wu LF, Chen XJ, Yan RM, Zhong M, Yu YH, Liang L, et al. MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2. Cell Death Dis. 2017;8:3220. PMID:29242498. doi:10.1038/s41419-017-0077-5.
   PubMed Web of Science ®Google Scholar
• Shi J, Zhang Y, Jin N, Li Y, Wu S, Xu L. MicroRNA-221-3p plays an oncogenic role in gastric carcinoma by inhibiting PTEN expression. Oncol Res. 2017;25:523–536. PMID:27712596. doi:10.3727/096504016X14756282819385.
   PubMed Web of Science ®Google Scholar
• Zhu J, Liu F, Wu Q, Liu X. MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN. Int J Mol Med. 2015;36:1377–1383. PMID:26397386. doi:10.3892/ijmm.2015.2352.
   PubMed Web of Science ®Google Scholar
• Yuan Q, Loya K, Rani B, Mobus S, Balakrishnan A, Lamle J, Cathomen T, Vogel A, Manns MP, Ott M, et al. MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration. Hepatology. 2013;57:299–310. PMID:22821679. doi:10.1002/hep.25984.
   PubMed Web of Science ®Google Scholar
• Dai R, Li J, Liu Y, Yan D, Chen S, Duan C, Liu X, He T, Li H. miR-221/222 suppression protects against endoplasmic reticulum stress-induced apoptosis via p27(Kip1)- and MEK/ERK-mediated cell cycle regulation. Biol Chem. 2010;391:791–801. PMID:20624000. doi:10.1515/BC.2010.072.
   PubMed Web of Science ®Google Scholar
• Xu Q, Li M, Yang M, Yang J, Xie J, Lu X, Wang F, Chen W. alpha-pinene regulates miR-221 and induces G2/M phase cell cycle arrest in human hepatocellular carcinoma cells. Biosci Rep. 2018;38. PMID:30473536. doi:10.1042/BSR20180980.
   Web of Science ®Google Scholar
• Huang S, Zhou D, Li YX, Ming ZY, Li KZ, Wu GB, Chen C, Zhao YN. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3. J Cell Physiol. 2019;234:3500–3514. PMID:30370582. doi:10.1002/jcp.26863.
   PubMed Web of Science ®Google Scholar
• Wu C, Zhang J, Cao X, Yang Q, Xia D. Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression. Med Sci Monit. 2016;22:2685–2690. PMID:27472451. doi:10.12659/msm.896404.
   PubMed Web of Science ®Google Scholar
• Hu XH, Zhao ZX, Dai J, Geng DC, Xu YZ. MicroRNA-221 regulates osteosarcoma cell proliferation, apoptosis, migration, and invasion by targeting CDKN1B/p27. J Cell Biochem. 2019;120:4665–4674. PMID:30582227. doi:10.1002/jcb.27755.
   PubMed Web of Science ®Google Scholar
• Gu C, Lu J, Cui T, Lu C, Shi H, Xu W, Yuan X, Yang X, Huang Y, Lu M. Association between MGMT promoter methylation and non-small cell lung cancer: a meta-analysis. PLoS One. 2013;8:e72633. PMID:24086261. doi:10.1371/journal.pone.0072633.
   PubMedGoogle Scholar
• Yousuf A, Bhat MY, Pandith AA, Afroze D, Khan NP, Alam K, Shah P, Shah MA, Mudassar S. MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area. Cell Oncol (Dordr). 2014;37:245–252. PMID:25008999. doi:10.1007/s13402-014-0179-3.
   PubMed Web of Science ®Google Scholar
• Zekri AR, Bahnasy AA, Shoeab FE, Mohamed WS, El-Dahshan DH, Ali FT, Sabry GM, Dasgupta N, Daoud SS. Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinoma. J Adv Res. 2014;5:27–40. PMID:25685469. doi:10.1016/j.jare.2012.11.002.
   PubMedGoogle Scholar
• Matsukura S, Miyazaki K, Yakushiji H, Ogawa A, Chen Y, Sekiguchi M. Combined loss of expression of O6-methylguanine-DNA methyltransferase and hMLH1 accelerates progression of hepatocellular carcinoma. J Surg Oncol. 2003;82:194–200. PMID:12619064. doi:10.1002/jso.10209.
   PubMed Web of Science ®Google Scholar